Confirmed partial response at 220 mg indicates anti-tumor activity of APR-1051 in biomarker-defined cancersEarly clinical data suggest the ...
Current patterns of care: Referral to palliative care for patients with metastatic gynecologic cancer. Intravenous selenium to prevent oral mucositis in patients with lymphoma or myeloma undergoing ...
When you think of clinical trials for cancer, testing a new medication may come to mind. But drugs aren’t the only thing these trials investigate. There’s a growing world of nonpharmaceutical clinical ...
An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of. For patients with triple-negative breast cancer, there are now several clinical ...
From advancing cancer care for future generations to being monitored more closely for disease progression, there are plenty of reasons to consider joining a cancer clinical trial. If your current ...
Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by the University of California, San Francisco, researchers are doing just that.
The study published by Bastiaan M Privé and colleagues in The Lancet Oncology represents, to our knowledge, the first randomised phase 2 trial evaluating lutetium-177–PSMA-617 (177Lu-PSMA-617) in ...
Clinical trials are vital for developing safer, more effective metastatic breast cancer treatments, yet participation is low due to access and financial barriers. Trials progress through phases, from ...
We extracted 20,894 trials from Cancer.gov from the application programming interface (API) of the NCI CTRP. We quantified biomarker rates in cancer subtypes, described the geographic distribution of ...
Hormone patches are as good at controlling locally advanced prostate cancer as the injections typically used to deliver ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results